Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

Completed · Not applicable

Conditions studied: Leukemia, Lymphoma, Paraproteinemias, Multiple Myeloma, Myelodysplastic Syndromes

In brief

The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' conditions when their blood pressures drop and they are treated with intravenous fluids.

Key facts

Study ID

NCT01755000

Run by

Washington University School of Medicine

People needed

69

Starts

2012-12-01

Expected to finish

2013-04-01

Last updated by the study team

2013-09-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 18 years of age
• English speaker
• Diagnosis of blood dyscrasia, hematopoietic malignancy, or condition that may requires HSCT

You may not qualify if…

• Obstruction of the suprasternal notch that prevents placing the USCOM probe in the correct location
• Tracheostomy or endotracheal tube that prevents placing USCOM probe in the correct location
• Inability to lie flat, on left or right side, or with the head of bed at a 30 degree angle for the USCOM exam (ex. due to respiratory distress or physiologic reasons)
• Impairment by a psychiatric, cognitive, or physiologic disorder that limits ability to understand explanation of study and give consent

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.